Strategic partnerships Neura Health has active collaboration with Eli Lilly and notable venture funding from major VC firms, indicating strong potential for co-development opportunities, pharmaceutical integrations, and larger enterprise partnerships in neurology care.

Scale through payor With neurology as a top five health plan expense and a proven tele-neurology network, there is a clear sales angle to partner with insurers and employers seeking cost savings and improved outcomes through virtual neurology services.

Enterprise expansion Recent expansions into employer sleep care and rapid neurology access suggest a readiness to scale with large employers and HR benefit programs, offering a proven path to B2B2C adoption and integrated care workflows.

Clinical outcomes Published peer-reviewed outcomes in 2022 and 2023 provide evidence of effectiveness, a strong differentiator for value-based contracts, health systems, and payors prioritizing quality metrics and patient satisfaction.

Growth signals Strong fundraising milestones, Series A led by the Go Red for Women Venture Fund, and rapid clinician-led service delivery indicate momentum that can be leveraged to secure multi-year, multi-site contracts with health plans and large employers.